MedPath

: A Comparison of Neuromuscular Transmission in the Muscles During General Anesthesia

Completed
Conditions
Neuromuscular Blockade
Interventions
Device: TOF Cuff on lower leg
Device: TOF Scan on toe
Device: TOF Cuff on arm
Device: TOF Scan on adductor pollicis
Device: TOF Scan on corrugator supercilii
Registration Number
NCT04845386
Lead Sponsor
University of Warmia and Mazury in Olsztyn
Brief Summary

The investigators want to compare new muscle relaxation monitoring, TOF-Cuff and TOF-Scan, during general anesthesia. Standard monitoring is using thumb, however it can't be use on every patient. Alternative can be eyebrow muscle or foot muscle.

There is only few old study that compares this muscle and used mivacurium. The study aims to compare TOF-Cuff and TOF-Scan with different sensor and use mivacurium.

Detailed Description

In our research in addition to the standard intraoperative monitoring, which includes the assessment of ECG and saturation, the investigators would like to estimate muscle relaxation by using two different methods: a TOF-Cuff which additionally allows to measure inoperative blood pressure and TOF-Scan with different sensor. Our aim is to compare two different methods of muscle relaxation monitoring in patients who will administer muscle relaxant - mivacurium. After receiving painkillers and hypnotics, when the patient is falling asleep, the standard dose of mivacurium 0.2 mg / kg body weight will be administered. Then, painless simultaneous stimulation with TOF-Cuff and TOF-Scan devices will begin. Until intubation, measurements will be made in every 30 seconds and then every 5 minutes until extubation. Extubation will take place according to the guidelines when the TOF-Cuff measurement on the arm is greater than 0.9 - this is the value at which the patient is considered ready to start breathing on his own. The following will be documented: the initiation of drug administration, intubation, possible repeated doses of mivacurium 2 mg, antagonization, extubation, possible side effects (e.g., transient cardiac disturbances, reddening of the skin, lowering blood pressure, bronchospasm, erythema, urticaria) and technical problems.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Age 18-75
  • ASA classification I,II,III
  • Elective surgery
  • BMI(body mass index) 17-35
  • Surgery in the supine position
  • Informed consent of the patient
Exclusion Criteria
  • Pregnancy and breastfeeding
  • Urgent indications for surgery
  • ASA classification >III
  • Neuromuscular diseases
  • Polyneuropathy
  • Diabetes
  • Drug addiction
  • Family history of malignant hyperthermia
  • Allergic to propofol, fentanyl or mivacurium

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TOF Cuff on lower leg and TOF Scan on adductor pollicisTOF Cuff on lower legPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Scan on adductor pollicis and TOF Scan on toeTOF Scan on toePatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Cuff on lower leg and TOF Scan on adductor pollicisTOF Scan on adductor pollicisPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Scan on adductor pollicis and TOF Scan on toeTOF Scan on adductor pollicisPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Scan on adductor pollicis and TOF Cuff on armTOF Scan on adductor pollicisPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Cuff on arm and TOF Scan on corrugator superciliiTOF Cuff on armPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Cuff on arm and TOF Scan on corrugator superciliiTOF Scan on corrugator superciliiPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Scan on adductor pollicis and TOF Cuff on armTOF Cuff on armPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Scan on adductor pollicis and TOF Scan on corrugator superciliiTOF Scan on adductor pollicisPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
TOF Scan on adductor pollicis and TOF Scan on corrugator superciliiTOF Scan on corrugator superciliiPatients undergoing surgery with intubation and receiving a intubation dose of mivacurium (0.2 mg/kg) and repeated dose of mivacurium (2mg) depending of needing under, routine gas anesthesia will have monitoring of neuromuscular block with two monitors simultaneously.
Primary Outcome Measures
NameTimeMethod
Onset time1 to 10 minutes

Time in seconds from start of injection of mivacurium until emergence of TOF ratio of 0%. TOF = Train of Four

Total recovery time of neuromuscular block30 to 500 minutes

The total recovery time, i.e. total duration of the neuromuscular block is defined as the time in minutes from start of injection of mivacurium until a normalized TOF ratio of 90%

Secondary Outcome Measures
NameTimeMethod
Time to repeated dose5 to 200 minutes

Time in minuted from TOF ratio 0% to repeated dose

Trial Locations

Locations (1)

Anesthesiology and Intensive Care Clinical Ward, Regional Specialized Hospital

🇵🇱

Olsztyn, Warmia-Mazury, Poland

Anesthesiology and Intensive Care Clinical Ward, Regional Specialized Hospital
🇵🇱Olsztyn, Warmia-Mazury, Poland
© Copyright 2025. All Rights Reserved by MedPath